Cite
Selective CDK9 Inhibition by Natural Compound Toyocamycin in Cancer Cells
MLA
Somnath Pandey, et al. “Selective CDK9 Inhibition by Natural Compound Toyocamycin in Cancer Cells.” Cancers, vol. 14, no. 14, May 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d0f60ee5ead9224e5c7fe751e8c2e539&authtype=sso&custid=ns315887.
APA
Somnath Pandey, Rahinatou Djibo, Anaïs Darracq, Gennaro Calendo, Hanghang Zhang, Ryan A. Henry, Andrew J. Andrews, Stephen B. Baylin, Jozef Madzo, Rafael Najmanovich, Jean-Pierre J. Issa, & Noël J.-M. Raynal. (2022). Selective CDK9 Inhibition by Natural Compound Toyocamycin in Cancer Cells. Cancers, 14(14).
Chicago
Somnath Pandey, Rahinatou Djibo, Anaïs Darracq, Gennaro Calendo, Hanghang Zhang, Ryan A. Henry, Andrew J. Andrews, et al. 2022. “Selective CDK9 Inhibition by Natural Compound Toyocamycin in Cancer Cells.” Cancers 14 (14). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d0f60ee5ead9224e5c7fe751e8c2e539&authtype=sso&custid=ns315887.